Chen, E. C., Fathi, A. T., & Brunner, A. M. (2018). Reformulating acute myeloid leukemia: Liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML. Onco Targets Ther.
শিকাগো স্টাইলে সাইটেশনChen, Evan C., Amir T. Fathi, এবং Andrew M. Brunner. "Reformulating Acute Myeloid Leukemia: Liposomal Cytarabine and Daunorubicin (CPX-351) As an Emerging Therapy for Secondary AML." Onco Targets Ther 2018.
এমএলএ সাইটেশনChen, Evan C., Amir T. Fathi, এবং Andrew M. Brunner. "Reformulating Acute Myeloid Leukemia: Liposomal Cytarabine and Daunorubicin (CPX-351) As an Emerging Therapy for Secondary AML." Onco Targets Ther 2018.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.